Director at Innovex International (INVX) receives 5,465-share equity grant

Rhea-AI Filing Summary

Innovex International, Inc. director Jupp Terence Bartlett reported an award of 5,465 shares of common stock on February 27, 2026. The shares were acquired as a grant at a stated price of $0.00 per share, bringing his directly held stake to 89,832 common shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jupp Terence Bartlett

(Last) (First) (Middle)

19120 KENSWICK DR.

(Street)

HUMBLE TX 77338

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Innovex International, Inc. [ INVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		5,465	A	$0	89,832	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Matt Steinheider, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Innovex International (INVX) disclose?

Innovex International disclosed that director Jupp Terence Bartlett received an award of 5,465 shares of common stock. The transaction was reported as a grant or other acquisition, rather than an open-market purchase or sale, under a Form 4 insider filing.

How many Innovex International (INVX) shares did the director acquire?

Director Jupp Terence Bartlett acquired 5,465 shares of Innovex International common stock. The filing classifies this as a grant or award, meaning the shares were received rather than bought in the market, and they increased his directly held ownership position.

At what price were the Innovex International (INVX) shares granted?

The 5,465 Innovex International common shares were granted at a stated price of $0.00 per share. This pricing indicates the shares were awarded to the director, rather than purchased, consistent with typical equity compensation or similar non-cash share grants.

What is Jupp Terence Bartlett’s Innovex International (INVX) ownership after the grant?

After receiving the 5,465-share grant, director Jupp Terence Bartlett directly owns 89,832 shares of Innovex International common stock. This total reflects his holdings immediately following the reported Form 4 transaction on February 27, 2026.

Was the Innovex International (INVX) insider transaction a buy or a grant?

The Innovex International insider transaction was a grant or award, not an open-market buy. The Form 4 uses transaction code “A,” described as a grant, award, or other acquisition, with a reported price of $0.00 per share for the 5,465 common shares.